Clinical Report: A Closer Look at the Complete Genome
Overview
Researchers have developed a nearly complete diploid genome benchmark, T2T-HG002 version 1.1, which covers 99.4% of the diploid genome without detectable errors. This benchmark provides a resource for genomic assessments, particularly in challenging regions that traditional reference-based methods struggle to evaluate.
Background
The development of accurate genomic benchmarks is crucial for sequencing and genomic analysis methods. Existing reference genomes often fall short in repetitive and structurally complex regions, leading to gaps in variant detection. The new benchmark provides a comprehensive resource for laboratories to assess genomic methods.
Data Highlights
The T2T-HG002 version 1.1 benchmark covers 99.4% of the diploid genome, with 99.35% free of detectable errors. It includes 701.4 Mb of high-confidence autosomal sequence not present in previous benchmarks.
Key Findings
- The T2T-HG002 benchmark covers 99.4% of the diploid genome.
- 99.35% of the genome is free of detectable errors.
- 701.4 Mb of high-confidence autosomal sequence was added compared to GIAB version 4.2.1.
- Genome Quality Checker software was developed to evaluate genomic methods against the benchmark.
- Conventional variant calling against GRCh38 covers approximately 93% of HG002, while de novo assembly covers 99.94%.
- Copy-number differences were identified in genes such as DUSP22 and GSTM1 between maternal and paternal genomes.
Clinical Implications
Laboratories can utilize the Genome Quality Checker software to evaluate sequencing methods against the benchmark.
Conclusion
The T2T-HG002 benchmark provides a resource for laboratories to assess sequencing accuracy.
Related Resources & Content
- NIST, Genome in a Bottle, 2025 -- Reference Genome Refresh
- The Medicine Maker, 2025 -- Illuminating the “Dark Regions” of the Genome
- The Analytical Scientist, 2012 -- The Tools Behind Genomics
- The Pathologist, 2026 -- Mapping the Genome in 4D
- Best Practices for Benchmarking Germline Small Variant Calls in Human Genomes - PMC
- the pathologist — Reference Genome Refresh
- Genome in a Bottle | NIST
- Best Practices for Benchmarking Germline Small Variant Calls in Human Genomes - PMC
- Clinical Utility of Rapid Whole-Genome Sequencing in Hospitalized Adults With Unexplained Neurologic Presentations | Neurology
Based on findings from:
A Closer Look at the Complete Genome
The Pathologist, 2026.
https://www.thepathologist.com/issues/2026/articles/august/a-closer-look-at-the-complete-genome/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.